This is a StreetInsider.com Premium Only Page

Merck (MRK) – StreetInsider.com Reports

Apr 8, 2024 04:54 AM Merck (MRK) PT Raised to $143 at Berenberg

Apr 4, 2024 06:45 AM Merck (MRK) Initiates Phase 3 Clinical Trial of MK-1084

Apr 3, 2024 08:04 AM Daiichi Sankyo and Merck (MRK) Announce REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer

Mar 28, 2024 06:46 AM Merck (MRK) Announces EU Approval of KEYTRUDA Plus Chemotherapy for NSCLC

Mar 27, 2024 11:43 AM Midday movers: GameStop falls; Merck, Robinhood and Moderna rise

Mar 27, 2024 08:53 AM Merck (MRK) PT Raised to $142 at Truist Securities

Mar 27, 2024 08:13 AM Merck (MRK) PT Raised to $135 at Wells Fargo

Mar 27, 2024 07:54 AM Merck (MRK) PT Raised to $145 at Jefferies, 'modeling a strong launch out of the gate' for Winrevair

Mar 27, 2024 06:06 AM Merck hits record high after FDA approves lung disease drug

Mar 27, 2024 04:44 AM Truist Securities Reiterates Buy Rating on Merck (MRK)

Mar 26, 2024 05:14 PM Merck's (MRK) Sotatercept Approved by FDA for High Blood Pressure

Mar 26, 2024 05:11 PM US FDA approves Merck's therapy for rare lung condition

Mar 26, 2024 05:04 PM After-hours movers: Merck, GameStop, Shockwave Medical, and more

Mar 21, 2024 06:45 AM Merck (MRK) Provides Update on Phase 3 KEYLYNK-006 Trial of KEYTRUDA Plus Maintenance LYNPARZA

Mar 19, 2024 04:33 PM Merck (MRK) Files for Debt Offering

Mar 19, 2024 09:02 AM Merck (MRK) Announces Positive Data on V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults, Demonstrated Immune Responses in Adults

Mar 17, 2024 08:00 PM Top pharma stocks to own in 2024 – Citi

Mar 15, 2024 06:45 AM Merck (MRK) Reports KEYTRUDA Plus Chemoradiotherapy Significantly Improved OS Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer

Mar 12, 2024 06:01 AM IDEAYA Biosciences (IDYA) to Evaluate IDE161 in Combination with KEYTRUDA

Mar 11, 2024 12:47 PM Societe Generale Downgrades Merck (MRK) to Sell

Mar 11, 2024 10:21 AM Moderna (MRNA) Trades at High, Up 9%

Mar 11, 2024 08:15 AM Merck (MRK) Completes Acquisition of Harpoon Therapeutics

Mar 6, 2024 10:25 AM Gilead Sciences (GILD) and Merck (MRK) Report Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24

Mar 1, 2024 05:22 AM Goldman Makes New Monthly Adjustments to Directors Cut Names, 'inclusion on this list is not a stock rating'

Feb 23, 2024 06:23 AM Merck (MRK) Reports Positive EU CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for the Treatment of Resectabl

Feb 23, 2024 06:21 AM Merck's (MRK) Keytruda receives positive CHMP opinion to expand Keytruda for certain non-small cell lung carcinoma

Feb 21, 2024 05:14 AM Merck (MRK) PT Raised to $140 at Berenberg

Feb 20, 2024 06:45 AM Merck (MRK) Granted FDA Priority Review for KEYTRUDA Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial Carcinoma

Feb 7, 2024 07:39 AM Merck (MRK) PT Raised to $140 at Argus

Feb 5, 2024 06:33 AM Merck Animal Health (MRK) Acquires Elanco’s (ELAN) Aqua Business for $1.3B Cash

Feb 5, 2024 04:16 AM Merck (MRK) PT Raised to $143 at DZ Bank

Feb 2, 2024 08:08 AM Merck (MRK) PT Raised to $130 at Wells Fargo

Feb 2, 2024 07:45 AM Merck (MRK) PT Raised to $148 at UBS

Feb 2, 2024 07:30 AM Merck (MRK) PT Raised to $139 at Truist Securities

Feb 2, 2024 04:14 AM Merck (MRK) PT Raised to $134 at Goldman Sachs

Feb 2, 2024 03:21 AM Merck (MRK) PT Raised to $145 at Barclays

Feb 1, 2024 01:24 PM Merck (MRK) PT Raised to $140 at Jefferies

Feb 1, 2024 12:02 PM Midday movers: Ferrari races higher, Qualcomm sputters, and more

Feb 1, 2024 11:25 AM US stocks rise ahead of more mega-cap tech earnings

Feb 1, 2024 09:48 AM Merck (MRK) looking at deals up to $15B - CEO

Feb 1, 2024 07:00 AM Goldman Sachs just released the list of top stocks to own in February

Feb 1, 2024 06:47 AM Keytruda strength fuels earnings beat for Merck (MRK)

Feb 1, 2024 06:33 AM Merck seeks more deals to prepare for Keytruda's revenue decline

Feb 1, 2024 06:31 AM Merck (MRK) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY24 Guidance

Feb 1, 2024 04:25 AM Merck (MRK) February weekly 121 straddle into quarter results

Jan 31, 2024 11:00 AM Merck (MRK) February weekly option implied volatility into quarter results

Jan 31, 2024 05:46 AM Merck (MRK) February weekly 121 straddle into quarter results

Jan 30, 2024 10:52 AM Merck (MRK) PT Raised to $127 at Morgan Stanley

Jan 29, 2024 06:11 AM Merck (MRK) PT Raised to $130 at Guggenheim

Jan 29, 2024 05:54 AM Merck's (MRK) KEYTRUDA Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC)